Kindred - Humana Buying

The acquisition of Kindred at Home (KAH) by Humana was a multi-year strategic process that concluded in 2021, marking a significant shift toward integrated, home-based care. Humana first purchased a 40% stake in the company for $800 million in 2018 through a joint venture with private equity firms TPG Capital and Welsh, Carson, Anderson & Stowe. In August 2021, Humana fully acquired the remaining 60% for approximately $5.7 billion, making Kindred at Home a wholly owned subsidiary.

Humana’s path to ownership was methodical. Starting with a 40% minority stake in 2018, the insurer spent three years integrating Kindred’s clinical expertise into its value-based care ecosystem before buying the remaining interest in 2021. This allowed Humana to scale its capabilities gradually, eventually creating the nation's largest home health provider. humana buying kindred

Beyond the Hospital: Why Humana’s Full Acquisition of Kindred at Home Matters The acquisition of Kindred at Home (KAH) by

Kindred at Home brought a massive infrastructure of 43,000 clinicians serving over 550,000 patients annually. For Humana, the primary driver was the ability to manage complex, high-risk patient populations —particularly those with chronic comorbidities who are significantly more likely to face frequent hospitalizations. Inside the Kindred Deal…and Why It Makes Sense Humana’s path to ownership was methodical

The healthcare landscape is shifting from clinical corridors to the comfort of the living room. Humana’s completion of its Kindred at Home acquisition isn't just a corporate merger; it’s a full-scale commitment to a "home-first" care model that aims to improve patient outcomes while lowering costs.